Issue
ATP-Binding Cassette transporters' gene expression in pediatric patients with acute leukemia; a comprehensive analysis of published reports through PubMed search engine
Corresponding Author(s) : Abolfazl Movafagh
Cellular and Molecular Biology,
Vol. 65 No. 2: Issue 2
Abstract
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
- Lage H. An overview of cancer multidrug resistance: a still unsolved problem. Cellular and molecular life sciences. 2008;65(20):3145-67.
- Biedler JL, Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer research. 1970;30(4):1174-84.
- Vasiliou V, Vasiliou K, Nebert DW. Human ATP-binding cassette (ABC) transporter family. Human genomics. 2009;3(3):281.
- Kathawala RJ, Gupta P, Ashby CR, Chen Z-S. The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade. Drug Resistance Updates. 2015;18:1-17.
- Steinbach D, Legrand O. ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra? Leukemia. 2007;21(6):1172-6.
- Schaich M, Soucek S, Thiede C, Ehninger G, Illmer T. MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia. British journal of haematology. 2005;128(3):324-32.
- Van den Heuvel-Eibrink M, Wiemer E, Prins A, Meijerink J, Vossebeld P, van der Holt B, et al. Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML). Leukemia (08876924). 2002;16(5).
- Tsimberidou A-M, Paterakis G, Androutsos G, Anagnostopoulos N, Galanopoulos A, Kalmantis T, et al. Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia. Leukemia research. 2002;26(2):143-54.
- Medicine USNLo. PubMed 1996. Available from: www.ncbi.nlm.nih.gov/pubmed/.
- Gurbuxani S, Arya LS, Raina V, Sazawal S, Khattar A, Magrath I, et al. Significance of MDR1, MRP1, GSTπ and GSTμ mRNA expression in acute lymphoblastic leukemia in Indian patients. Cancer letters. 2001;167(1):73-83.
- Gurbuxani S, Zhou D, Simonin G, Raina V, Arya L, Sazawal S, et al. Expression of genes implicated in multidrug resistance in acute lymphoblastic leukemia in India. Annals of hematology. 1998;76(5):195-200.
- Sauerbrey A, Voigt A, Wittig S, Häfer R, Zintl F. Messenger RNA analysis of the multidrug resistance related protein (MRP1) and the lung resistance protein (LRP) in de novo and relapsed childhood acute lymphoblastic leukemia. Leukemia & lymphoma. 2002;43(4):875-9.
- Plasschaert SL, de Bont ES, Boezen M, vander Kolk DM, Daenen SM, Faber KN, et al. Expression of multidrug resistance–associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia. Clinical Cancer Research. 2005;11(24):8661-8.
- Hamidah N. Assessment of P-gp and MRP1 activities using MultiDrugQuantâ„¢ Assay Kit: a preliminary study of correlation between protein expressions and its functional activities in newly diagnosed acute leukaemia patients. Malays J Pathol. 2008;30:87-93.
- Bhatia P, Masih S, Varma N, Bansal D, Trehan A. High Expression of Lung Resistance Protein mRNA at Diagnosis Predicts Poor Early Response to Induction Chemotherapy in Childhood Acute Lymphoblastic Leukemia. Asian Pacific Journal of Cancer Prevention. 2015;16(15):6663-8.
- Li YQ, Gopal V, Kadam P, Files S, Preisler H. The multiple drug resistance gene, MDR 1: Expression at the protein and RNA levels. Medical Oncology. 1992;9(1):3-9.
- Kasimir-Bauer S, Beelen D, Flasshove M, Noppeney R, Seeber S, Scheulen ME. Impact of the expression of P glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat shock protein 27 on response to induction therapy and long-term survival in patients with de novo acute myeloid leukemia. Experimental hematology. 2002;30(11):1302-8.
- Campbell PK, Zong Y, Yang S, Zhou S, Rubnitz JE, Sorrentino BP. Identification of a novel, tissue-specific ABCG2 promoter expressed in pediatric acute megakaryoblastic leukemia. Leukemia research. 2011;35(10):1321-9.
- Shman T, Savitskii V, Potapnev M, Aleinikova O. Study of expression and functional activity of P-GP membrane glycoprotein in children with acute leukemia. Bulletin of experimental biology and medicine. 2006;141(6):727-30.
- Gekeler V, Frese G, Noller A, Handgretinger R, Wilisch A, Schmidt H, et al. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase π gene expression in primary and relapsed state adult and childhood leukaemias. British journal of cancer. 1992;66(3):507-17.
- Wells RJ, Odom LF, Gold SH, Feusner J, Krill CE, Waldron P, et al. Cytosine arabinoside and mitoxantrone treatment of relapsed or refractory childhood leukemia: initial response and relationship to multidrug resistance gene 1. Pediatric Blood & Cancer. 1994;22(4):244-9.
- Huh HJ, Park C-J, Jang S, Seo E-J, Chi H-S, Lee J-H, et al. Prognostic Significance of Multidrug Resistance Gene 1 (MDR1), Multidrug Resistance-Related Protein (MRP) and Lung Resistance Protein (LRP) mRNA Expression in Acute Leukemia. Am Soc Hematology; 2005.
- Svirnovski AI, Shman TV, Serhiyenka TF, Savitski VP, Smolnikova VV, Fedasenka UU. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells. Hematology. 2009;14(4):204-12.
- de Moraes ACR, Licínio MA, Zampirolo JA, Liedke SC, Del Moral Jí‚G, Machado MJ, et al. Evaluation of multidrug resistance in 46 newly diagnosed patients with acute leukemia. Hematology. 2012;17(2):59-65.
- Farawela HM, Khorshied MM, Kassem NM, Kassem HA, Zawam HM. The clinical relevance and prognostic significance of adenosine triphosphate ATP-binding cassette (ABCB5) and multidrug resistance (MDR1) genes expression in acute leukemia: an Egyptian study. Journal of cancer research and clinical oncology. 2014;140(8):1323-30.
- de Moraes ACR, Maranho CK, Rauber GS, Santos"Silva MC. Importance of detecting multidrug resistance proteins in acute leukemia prognosis and therapy. Journal of clinical laboratory analysis. 2013;27(1):62-71.
- Jaramillo AC, Al Saig F, Cloos J, Jansen G, Peters GJ. How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance. Cancer Drug Resist. 2018;1:6-29.
- Binkhathlan Z, Lavasanifar A. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives. Current cancer drug targets. 2013;13(3):326-46.
- Dhooge C, De Moerloose B, Laureys G, Kint J, Ferster A, De Bacquer D, et al. P"glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: results of a 6"year prospective study. British journal of haematology. 1999;105(3):676-83.
- Wuchter C, Leonid K, Ruppert V, Schrappe M, Buchner T, Schoch C, et al. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia. Haematologica. 2000;85(7):711-21.
- Fujimaki S-i, Funato T, Harigae H, Fujiwara J, Kameoka J, Meguro K, et al. Quantitative analysis of a MDR1 transcript for prediction of drug resistance in acute leukemia. Clinical chemistry. 2002;48(6):811-7.
- Schaich M, Soucek S, Thiede C, Ehninger G, Illmer T. MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia. British journal of haematology. 2005;128(3):324-32.
- Benderra Z, Faussat AM, Sayada L, Perrot J-Y, Tang R, Chaoui D, et al. MRP3, BCRP, and P-glycoprotein activities are prognostic factors in adult acute myeloid leukemia. Clinical cancer research. 2005;11(21):7764-72.
- Olson DP, Taylor BJ, La M, Sather H, Reaman GH, Ivy SP. The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: a retrospective study of 295 newly diagnosed patients by the Children's Oncology Group. Leukemia & lymphoma. 2005;46(5):681-91.
- Fedasenka U, Shman T, Savitski V, Belevcev M. Expression of MDR1, LRP, BCRP and Bcl-2 genes at diagnosis of childhood all: comparison with MRD status after induction therapy. Exp Oncol. 2008;30(3):248-52.
- van Grotel M, van den Heuvel"Eibrink MM, van Wering ER, van Noesel MM, Kamps WA, Veerman AJ, et al. CD34 expression is associated with poor survival in pediatric T"cell acute lymphoblastic leukemia. Pediatric blood & cancer. 2008;51(6):737-40.
- Scheiner MAM, da Cunha Vasconcelos F, da Matta RR, Figueira RDB, Maia RC. ABCB1 genetic variation and P-glycoprotein expression/activity in a cohort of Brazilian acute myeloid leukemia patients. Journal of cancer research and clinical oncology. 2012;138(6):959-69.
- Huh HJ, Park C-J, Jang S, Seo E-J, Chi H-S, Lee J-H, et al. Prognostic significance of multidrug resistance gene 1 (MDR1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) mRNA expression in acute leukemia. Journal of Korean medical science. 2006;21(2):253-8.
- Styczynski J, Wysocki M, Debski R, Czyzewski K, Kolodziej B, Rafinska B, et al. Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia. Journal of cancer research and clinical oncology. 2007;133(11):875-93.
- de Figueiredo"Pontes LL, Pintí£o MCT, Oliveira LC, Dalmazzo LF, Jácomo RH, Garcia AB, et al. Determination of P"glycoprotein, MDR"related protein 1, breast cancer resistance protein, and lung"resistance protein expression in leukemic stem cells of acute myeloid leukemia. Cytometry Part B: Clinical Cytometry. 2008;74(3):163-8.
- El-Sharnouby JA, Abou El-Enein AM, El Ghannam DM, El-Shanshory MR, Hagag AA, Yahia S, et al. Expression of lung resistance protein and multidrug resistance-related protein (MRP1) in pediatric acute lymphoblastic leukemia. Journal of Oncology Pharmacy Practice. 2010;16(3):179-88.
- Chauhan PS, Bhushan B, Singh L, Mishra AK, Saluja S, Mittal V, et al. Expression of genes related to multiple drug resistance and apoptosis in acute leukemia: response to induction chemotherapy. Experimental and molecular pathology. 2012;92(1):44-9.
References
Lage H. An overview of cancer multidrug resistance: a still unsolved problem. Cellular and molecular life sciences. 2008;65(20):3145-67.
Biedler JL, Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer research. 1970;30(4):1174-84.
Vasiliou V, Vasiliou K, Nebert DW. Human ATP-binding cassette (ABC) transporter family. Human genomics. 2009;3(3):281.
Kathawala RJ, Gupta P, Ashby CR, Chen Z-S. The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade. Drug Resistance Updates. 2015;18:1-17.
Steinbach D, Legrand O. ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra? Leukemia. 2007;21(6):1172-6.
Schaich M, Soucek S, Thiede C, Ehninger G, Illmer T. MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia. British journal of haematology. 2005;128(3):324-32.
Van den Heuvel-Eibrink M, Wiemer E, Prins A, Meijerink J, Vossebeld P, van der Holt B, et al. Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML). Leukemia (08876924). 2002;16(5).
Tsimberidou A-M, Paterakis G, Androutsos G, Anagnostopoulos N, Galanopoulos A, Kalmantis T, et al. Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia. Leukemia research. 2002;26(2):143-54.
Medicine USNLo. PubMed 1996. Available from: www.ncbi.nlm.nih.gov/pubmed/.
Gurbuxani S, Arya LS, Raina V, Sazawal S, Khattar A, Magrath I, et al. Significance of MDR1, MRP1, GSTπ and GSTμ mRNA expression in acute lymphoblastic leukemia in Indian patients. Cancer letters. 2001;167(1):73-83.
Gurbuxani S, Zhou D, Simonin G, Raina V, Arya L, Sazawal S, et al. Expression of genes implicated in multidrug resistance in acute lymphoblastic leukemia in India. Annals of hematology. 1998;76(5):195-200.
Sauerbrey A, Voigt A, Wittig S, Häfer R, Zintl F. Messenger RNA analysis of the multidrug resistance related protein (MRP1) and the lung resistance protein (LRP) in de novo and relapsed childhood acute lymphoblastic leukemia. Leukemia & lymphoma. 2002;43(4):875-9.
Plasschaert SL, de Bont ES, Boezen M, vander Kolk DM, Daenen SM, Faber KN, et al. Expression of multidrug resistance–associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia. Clinical Cancer Research. 2005;11(24):8661-8.
Hamidah N. Assessment of P-gp and MRP1 activities using MultiDrugQuantâ„¢ Assay Kit: a preliminary study of correlation between protein expressions and its functional activities in newly diagnosed acute leukaemia patients. Malays J Pathol. 2008;30:87-93.
Bhatia P, Masih S, Varma N, Bansal D, Trehan A. High Expression of Lung Resistance Protein mRNA at Diagnosis Predicts Poor Early Response to Induction Chemotherapy in Childhood Acute Lymphoblastic Leukemia. Asian Pacific Journal of Cancer Prevention. 2015;16(15):6663-8.
Li YQ, Gopal V, Kadam P, Files S, Preisler H. The multiple drug resistance gene, MDR 1: Expression at the protein and RNA levels. Medical Oncology. 1992;9(1):3-9.
Kasimir-Bauer S, Beelen D, Flasshove M, Noppeney R, Seeber S, Scheulen ME. Impact of the expression of P glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat shock protein 27 on response to induction therapy and long-term survival in patients with de novo acute myeloid leukemia. Experimental hematology. 2002;30(11):1302-8.
Campbell PK, Zong Y, Yang S, Zhou S, Rubnitz JE, Sorrentino BP. Identification of a novel, tissue-specific ABCG2 promoter expressed in pediatric acute megakaryoblastic leukemia. Leukemia research. 2011;35(10):1321-9.
Shman T, Savitskii V, Potapnev M, Aleinikova O. Study of expression and functional activity of P-GP membrane glycoprotein in children with acute leukemia. Bulletin of experimental biology and medicine. 2006;141(6):727-30.
Gekeler V, Frese G, Noller A, Handgretinger R, Wilisch A, Schmidt H, et al. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase π gene expression in primary and relapsed state adult and childhood leukaemias. British journal of cancer. 1992;66(3):507-17.
Wells RJ, Odom LF, Gold SH, Feusner J, Krill CE, Waldron P, et al. Cytosine arabinoside and mitoxantrone treatment of relapsed or refractory childhood leukemia: initial response and relationship to multidrug resistance gene 1. Pediatric Blood & Cancer. 1994;22(4):244-9.
Huh HJ, Park C-J, Jang S, Seo E-J, Chi H-S, Lee J-H, et al. Prognostic Significance of Multidrug Resistance Gene 1 (MDR1), Multidrug Resistance-Related Protein (MRP) and Lung Resistance Protein (LRP) mRNA Expression in Acute Leukemia. Am Soc Hematology; 2005.
Svirnovski AI, Shman TV, Serhiyenka TF, Savitski VP, Smolnikova VV, Fedasenka UU. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells. Hematology. 2009;14(4):204-12.
de Moraes ACR, Licínio MA, Zampirolo JA, Liedke SC, Del Moral Jí‚G, Machado MJ, et al. Evaluation of multidrug resistance in 46 newly diagnosed patients with acute leukemia. Hematology. 2012;17(2):59-65.
Farawela HM, Khorshied MM, Kassem NM, Kassem HA, Zawam HM. The clinical relevance and prognostic significance of adenosine triphosphate ATP-binding cassette (ABCB5) and multidrug resistance (MDR1) genes expression in acute leukemia: an Egyptian study. Journal of cancer research and clinical oncology. 2014;140(8):1323-30.
de Moraes ACR, Maranho CK, Rauber GS, Santos"Silva MC. Importance of detecting multidrug resistance proteins in acute leukemia prognosis and therapy. Journal of clinical laboratory analysis. 2013;27(1):62-71.
Jaramillo AC, Al Saig F, Cloos J, Jansen G, Peters GJ. How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance. Cancer Drug Resist. 2018;1:6-29.
Binkhathlan Z, Lavasanifar A. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives. Current cancer drug targets. 2013;13(3):326-46.
Dhooge C, De Moerloose B, Laureys G, Kint J, Ferster A, De Bacquer D, et al. P"glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: results of a 6"year prospective study. British journal of haematology. 1999;105(3):676-83.
Wuchter C, Leonid K, Ruppert V, Schrappe M, Buchner T, Schoch C, et al. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia. Haematologica. 2000;85(7):711-21.
Fujimaki S-i, Funato T, Harigae H, Fujiwara J, Kameoka J, Meguro K, et al. Quantitative analysis of a MDR1 transcript for prediction of drug resistance in acute leukemia. Clinical chemistry. 2002;48(6):811-7.
Schaich M, Soucek S, Thiede C, Ehninger G, Illmer T. MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia. British journal of haematology. 2005;128(3):324-32.
Benderra Z, Faussat AM, Sayada L, Perrot J-Y, Tang R, Chaoui D, et al. MRP3, BCRP, and P-glycoprotein activities are prognostic factors in adult acute myeloid leukemia. Clinical cancer research. 2005;11(21):7764-72.
Olson DP, Taylor BJ, La M, Sather H, Reaman GH, Ivy SP. The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: a retrospective study of 295 newly diagnosed patients by the Children's Oncology Group. Leukemia & lymphoma. 2005;46(5):681-91.
Fedasenka U, Shman T, Savitski V, Belevcev M. Expression of MDR1, LRP, BCRP and Bcl-2 genes at diagnosis of childhood all: comparison with MRD status after induction therapy. Exp Oncol. 2008;30(3):248-52.
van Grotel M, van den Heuvel"Eibrink MM, van Wering ER, van Noesel MM, Kamps WA, Veerman AJ, et al. CD34 expression is associated with poor survival in pediatric T"cell acute lymphoblastic leukemia. Pediatric blood & cancer. 2008;51(6):737-40.
Scheiner MAM, da Cunha Vasconcelos F, da Matta RR, Figueira RDB, Maia RC. ABCB1 genetic variation and P-glycoprotein expression/activity in a cohort of Brazilian acute myeloid leukemia patients. Journal of cancer research and clinical oncology. 2012;138(6):959-69.
Huh HJ, Park C-J, Jang S, Seo E-J, Chi H-S, Lee J-H, et al. Prognostic significance of multidrug resistance gene 1 (MDR1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) mRNA expression in acute leukemia. Journal of Korean medical science. 2006;21(2):253-8.
Styczynski J, Wysocki M, Debski R, Czyzewski K, Kolodziej B, Rafinska B, et al. Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia. Journal of cancer research and clinical oncology. 2007;133(11):875-93.
de Figueiredo"Pontes LL, Pintí£o MCT, Oliveira LC, Dalmazzo LF, Jácomo RH, Garcia AB, et al. Determination of P"glycoprotein, MDR"related protein 1, breast cancer resistance protein, and lung"resistance protein expression in leukemic stem cells of acute myeloid leukemia. Cytometry Part B: Clinical Cytometry. 2008;74(3):163-8.
El-Sharnouby JA, Abou El-Enein AM, El Ghannam DM, El-Shanshory MR, Hagag AA, Yahia S, et al. Expression of lung resistance protein and multidrug resistance-related protein (MRP1) in pediatric acute lymphoblastic leukemia. Journal of Oncology Pharmacy Practice. 2010;16(3):179-88.
Chauhan PS, Bhushan B, Singh L, Mishra AK, Saluja S, Mittal V, et al. Expression of genes related to multiple drug resistance and apoptosis in acute leukemia: response to induction chemotherapy. Experimental and molecular pathology. 2012;92(1):44-9.